| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.957 | 1.315 | 516 | 8.648 | 10.624 | 14.150 | 15.519 | 17.081 | 20.677 |
| Total Income - EUR | - | 6.957 | 1.315 | 516 | 8.648 | 10.624 | 14.150 | 15.519 | 17.081 | 20.677 |
| Total Expenses - EUR | - | 2.888 | 1.084 | 102 | 1.583 | 1.881 | 3.031 | 3.960 | 4.375 | 6.181 |
| Gross Profit/Loss - EUR | - | 4.069 | 231 | 414 | 7.065 | 8.742 | 11.119 | 11.559 | 12.706 | 14.496 |
| Net Profit/Loss - EUR | - | 3.860 | 192 | 399 | 6.806 | 8.436 | 10.745 | 11.103 | 10.715 | 11.894 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farca Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 715 | 446 | 187 | 1.775 | 2.137 | 1.534 |
| Current Assets | - | 5.230 | 6.178 | 4.371 | 10.445 | 18.963 | 29.565 | 35.692 | 20.167 | 17.828 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 352 | 0 | 0 | 94 | 0 | 116 | 0 | 10.603 | 0 |
| Cash | - | 4.878 | 6.178 | 4.371 | 10.351 | 18.963 | 29.449 | 35.692 | 9.564 | 17.828 |
| Shareholders Funds | - | 3.905 | 4.030 | 4.355 | 11.076 | 19.302 | 29.619 | 11.357 | 22.038 | 16.328 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.325 | 2.148 | 16 | 83 | 108 | 133 | 26.110 | 266 | 3.035 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Farca Medical S.r.l.